Associate Professor, HSOR PhD Program
- West Virginia University School of Pharmacy
- Pharmaceutical Systems & Policy
- PhD, Psychology, Rutgers, The State University of New Jersey, 2000
- MS, Genetic Counseling, Indiana University, School of Medicine, Indianapolis, IN, 2002
Ten Most Recent:
A systematic review and meta-analysis of physical activity interventions among colorectal cancer survivors. Mbous, Y.P., Shah, J., Kelly, K.M.* (in press). Translational Behavioral Medicine (Diamond Anniversary special issue).
A systematic review of interventions using health behavioral theories to improve medication adherence among patients with hypertension. Nili, M., Mohamed, R., Kelly, K.M.* (in press). Translational Behavioral Medicine (Diamond Anniversary special issue).
Interest in tobacco cessation interventions among pharmacists and student pharmacists in a high prevalence state. Rai, P., Agarwal, P., Scott, V.G., Tworek, C., Elswick, B.M., Kelly, K.M.* Addictive Disorders & Their Treatment. 2020; 19(2): 108-117.
Insure Me Cancer Free: An intervention utilizing a Dynamic Communication Model. Kelly, K.M.*, Dolly, B., Kennedy, S., Atkins, E., Coon, M., King, K., Mbous, Y., Rouse, S. Health Behavior Research (Health Equity special issue) 2019; 2(1): 1-13.
Familial opioid misuse and family cohesion: Impact on family communication and well-being. Alhussain, K., Shah, D., Thornton, J.D., Kelly, K.M.* Addictive Disorders & Their Treatment 2019; 18(4): 194-204.
Impact of diffuse large B-cell lymphoma on visits to different provider specialties among elderly Medicare beneficiaries: challenges for care coordination. Garg, R., Sambamoorthi, U., Tan, X., Basu, S.K., Haggerty, T., Kelly, K.M.* Translational Behavioral Medicine (Coordination of Chronic Care special issue) 2018; 8(3): 386-399.
Receipt of guideline-concordant care among older women with stage I-III breast cancer: A population-based study. LeMasters, T., Madhavan, S., Sambamoorthi, U., Hazard, H., Kelly, K., Long, D. (2018). Journal of the National Comprehensive Cancer Network 2018; 16(6):703-710.
Dr. Kimberly Kelly is an Associate Professor in the Department of Pharmaceutical Systems and Policy in the School of Pharmacy and the West Virginia University Cancer Institute. She received her MS (1998) and PhD (2000) in social and health psychology from Rutgers University, her MS (2002) in genetic counseling from Indiana University, and completed a post-doctoral fellowship in cancer control and behavioral science at the University of Kentucky (2002-2004). Before joining West Virginia University, Dr. Kelly was a member of the Department of Molecular Virology, Immunology, and Medical Genetics, and was also affiliated with the Department of Psychology, Health Behavior and Health Promotion in the College of Public Health, the Primary Care Research Institute, and the Comprehensive Cancer Center at The Ohio State University.
Three overlapping themes emerge from Dr. Kelly’s research: (1) cancer risk perception/communication, (2) health behavior (e.g., cancer screening, genetic testing), and (3) elevated risk populations (e.g., Appalachians, those with a family history of cancer). Her work relies on behavioral theory from psychology (health, social, cognitive), as well as communication and information sciences. She mixes qualitative and quantitative methods, utilizing clinic-based and community-based approaches. Most of her research has focused on how risk is communicated in the context of cancer genetic counseling and how risk perceptions differ from objective estimates of risk. She also examines the role of risk perception in cancer screening. Through her research, Dr. Kelly hopes to understand how best to enhance appropriate decision-making about health behaviors in elevated risk populations to accomplish optimal health outcomes.
Program 2: Breast Cancer